Ashley Hall - Insider Trading & Ownership

Entity
Individual
Location
C/O Esperion Therapeutics Inc., 3891 Ranchero Drive Suite 150, Ann Arbor, MI
Summary
The estimated net worth of Ashley Hall is at least $249K dollars as of September 20, 2024. Ashley Hall is the Chief Development Officer of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $249K.
All Insider Reports
All Insider Reports

Ownership of Ashley Hall

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OKUR OnKure Therapeutics, Inc. Chief Development Officer $249K Aug 28, 2023
GPCR Structure Therapeutics Inc. Chief Development Officer Sep 18, 2024

Insider Transactions Reported by Ashley Hall:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.